LeonaBio (LONA) Amortization of Deferred Charges (2021 - 2026)

LeonaBio (LONA) has 6 years of Amortization of Deferred Charges data on file, last reported at $74000.0 in Q1 2026.

• On a quarterly basis, Amortization of Deferred Charges rose 13.85% year-over-year to $74000.0 in Q1 2026; TTM through Mar 2026 was $282000.0, a 13.25% increase from a year earlier, with the FY2025 full-year figure at $273000.0, up 13.28% from the prior year.
• Amortization of Deferred Charges for Q1 2026 stood at $74000.0, up from $72000.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for LONA reached as high as $74000.0 in Q1 2026 and fell as low as $45000.0 in Q1 2022.
• Historically, Amortization of Deferred Charges has averaged $59117.6 across 5 years, with a median of $59000.0 in 2024.
• Across the five-year window, Amortization of Deferred Charges surged 60.71% in 2022 and decreased 12.9% in 2023, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $49000.0 in 2022, then gained by 14.29% to $56000.0 in 2023, then gained by 12.5% to $63000.0 in 2024, then gained by 14.29% to $72000.0 in 2025, then gained by 2.78% to $74000.0 in 2026.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $74000.0 in Q1 2026, $72000.0 in Q4 2025, and $69000.0 in Q3 2025.